Novartis Pharmaceuticals Corp

FDA Filings

This page includes the latest FDA filings for Novartis Pharmaceuticals Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

• Registration Number: 3002037047
• FEI Number: 3002037047
• Name: S.A. ALCON-COUVREUR N.V.
• Owner & Operator: Novartis Pharmaceuticals Corporation
• Contact Address: One Health Plaza ; East Hanover NJ 07936 US
• Official Correspondent:
  • Corey Schmidt
  • x-862-7782266-x
• US Agent:
  • Corey Schmidt
  • Novartis Pharmaceutical Corporation
  • 862 7782266
  • corey.schmidt@novartis.com
• Registration Status: 1
• Initial Importer: N
• Registration Expiration: 2020-04-25
• Registration Address: RIJKSWEG 14 ; Puurs, 2870 BE
• Establishment Type: Manufacture Medical Device for Another Party (Contract Manufacturer)

FDA Filings

Device Company	Device	Date
Exelon Novartis Pharmaceuticals Corporation	Prescription Medication	2025-10-05
Trileptal Novartis Pharmaceuticals Corporation	Prescription Medication	2025-10-04
RHAPSIDO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-10-03
Ritalin Novartis Pharmaceuticals Corporation	Prescription Medication	2025-10-01
KISQALI Novartis Pharmaceuticals Corporation	Prescription Medication	2025-10-01
KISQALI FEMARA CO-PACK Novartis Pharmaceuticals Corporation	Prescription Medication	2025-10-01
KYMRIAH Novartis Pharmaceuticals Corporation	Other Medication	2025-09-28
TobraDex Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-28
Reclast Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-11
CIPRO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-10
CILOXAN Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-10
MAXITROL Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-10
Azopt Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-06
Gilenya Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-05
HYCAMTIN Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-05
Focalin Novartis Pharmaceuticals Corporation	Prescription Medication	2025-09-05
DUREZOL Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-31
MAYZENT Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-31
Femara Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-23
KESIMPTA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-23
Xiidra Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-20
PROMACTA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-20
Focalin Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-20
Mekinist Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-20
COSENTYX Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-17
TYKERB Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-14
Zortress Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-14
Sandimmune Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-14
TABRECTA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-14
Exjade Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-14
Afinitor Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-14
ENTRESTO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-14
Sandostatin LAR Depot Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-13
Sandostatin Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-13
Simulect Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-13
CIPRO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
Azopt Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
KISQALI Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
KISQALI FEMARA CO-PACK Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
CILOXAN Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
LEQVIO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
VIJOICE Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
MAXITROL Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-08
Diovan Novartis Pharmaceuticals Corporation	Prescription Medication	2025-08-02
Sandostatin LAR Depot Novartis Pharmaceuticals Corporation	Prescription Medication	2025-07-19
Myfortic Novartis Pharmaceuticals Corporation	Prescription Medication	2025-07-10
LOCAMETZ Advanced Accelerator Applications USA, Inc, Novartis Pharmaceuticals Corporation	Prescription Medication	2025-07-05
KYMRIAH Novartis Pharmaceuticals Corporation	Other Medication	2025-07-04
SCEMBLIX Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
Sandostatin LAR Depot Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
Neoral Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
Femara Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
Ilaris Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
LEQVIO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
KESIMPTA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
VIJOICE Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
MAYZENT Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
Gleevec Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
RYDAPT Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-20
PROMACTA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-19
Desferal Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-18
COARTEM Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-18
COSENTYX Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-18
ARZERRA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-18
Exjade Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-18
Sandimmune Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-13
VANRAFIA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-08
ADAKVEO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-06-04
Afinitor Novartis Pharmaceuticals Corporation	Prescription Medication	2025-05-15
Maxidex Novartis Pharmaceuticals Corporation	Prescription Medication	2025-05-04
Myfortic Novartis Pharmaceuticals Corporation	Prescription Medication	2025-05-03
Gilenya Novartis Pharmaceuticals Corporation	Prescription Medication	2025-05-03
Mekinist Novartis Pharmaceuticals Corporation	Prescription Medication	2025-04-12
Exforge Novartis Pharmaceuticals Corporation	Prescription Medication	2025-04-06
VANRAFIA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-04-06
LOCAMETZ Advanced Accelerator Applications USA, Inc, Novartis Pharmaceuticals Corporation	Prescription Medication	2025-04-06
Mekinist Novartis Pharmaceuticals Corporation	Prescription Medication	2025-04-06
TABRECTA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-04-03
FABHALTA Novartis Pharmaceuticals Corporation	Prescription Medication	2025-03-23
Mekinist Novartis Pharmaceuticals Corporation	Prescription Medication	2025-03-22
KYMRIAH Novartis Pharmaceuticals Corporation	Other Medication	2025-03-21
EGATEN Novartis Pharmaceuticals Corporation	Prescription Medication	2025-03-08
KISQALI Novartis Pharmaceuticals Corporation	Prescription Medication	2025-03-03
KISQALI FEMARA CO-PACK Novartis Pharmaceuticals Corporation	Prescription Medication	2025-03-03
Mekinist Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-28
TobraDex Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-26
BEOVU Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-26
TOBREX Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-26
PIQRAY Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-23
Tasigna Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-23
Ritalin Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-17
Afinitor Novartis Pharmaceuticals Corporation	Prescription Medication	2025-02-09
Betoptic S Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-23
ALOMIDE Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-23
KISQALI Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-22
Sandimmune Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-22
EGATEN Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-22
Sandostatin Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-22
Simulect Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-22
ENTRESTO Novartis Pharmaceuticals Corporation	Prescription Medication	2025-01-22
PMN P990023 | LZP S.A. ALCON-COUVREUR N.V. [Novartis Pharmaceuticals Corporation]	Cellugel	2019-04-29
PMN P890047 | LZP S.A. ALCON-COUVREUR N.V. [Novartis Pharmaceuticals Corporation]	Provisc	2019-04-29
PMN P840064 | LZP S.A. ALCON-COUVREUR N.V. [Novartis Pharmaceuticals Corporation]	Viscoat, Duovisc and DiscoVisc	2019-04-29
GUDID 47612799202391 NOVARTIS PHARMACEUTICALS CORPORATION	Extavia® Auto-Injector II	2018-10-25
NDC 0078-0675 Novartis Pharmaceuticals Corporation	ZOFRAN	2018-03-07
NDC 0078-0846 Novartis Pharmaceuticals Corporation	KYMRIAH	2017-08-30
NDC 0078-0672 Novartis Pharmaceuticals Corporation	HYCAMTIN	2017-07-07
NDC 0078-0713 Novartis Pharmaceuticals Corporation	Jadenu	2017-05-18
NDC 0078-0860 Novartis Pharmaceuticals Corporation	KISQALI	2017-03-13
NDC 0078-0734 Novartis Pharmaceuticals Corporation	Ilaris	2016-12-22
NDC 0078-0674 Novartis Pharmaceuticals Corporation	HYCAMTIN	2016-12-21
NDC 0078-0818 Novartis Pharmaceuticals Corporation	Sandostatin LAR Depot	2016-07-22
NDC 0078-0811 Novartis Pharmaceuticals Corporation	Sandostatin LAR Depot	2016-07-22
NDC 0078-0670 Novartis Pharmaceuticals Corporation	VOTRIENT	2016-07-12
NDC 0078-0682 Novartis Pharmaceuticals Corporation	Tafinlar	2016-04-12
NDC 0078-0662 Novartis Pharmaceuticals Corporation	SEEBRI NEOHALER	2015-10-29
NDC 0078-0659 Novartis Pharmaceuticals Corporation	ENTRESTO	2015-07-07
NDC 0078-0652 Novartis Pharmaceuticals Corporation	FARYDAK	2015-02-23
NDC 0078-0651 Novartis Pharmaceuticals Corporation	FARYDAK	2015-02-23
NDC 0078-0647 Novartis Pharmaceuticals Corporation	Sandostatin LAR Depot	2015-02-01
NDC 0078-0643 Novartis Pharmaceuticals Corporation	Signifor LAR	2014-12-15
NDC 0078-0642 Novartis Pharmaceuticals Corporation	Signifor LAR	2014-12-15
NDC 0078-0634 Novartis Pharmaceuticals Corporation	Signifor	2012-12-14
NDC 0078-0628 Novartis Pharmaceuticals Corporation	Afinitor Disperz	2012-08-29
NDC 0078-0594 Novartis Pharmaceuticals Corporation	Afinitor	2010-07-09
NDC 0078-0422 Novartis Pharmaceuticals Corporation	Zortress	2010-04-22
NDC 0078-0417 Novartis Pharmaceuticals Corporation	Zortress	2010-04-22
NDC 0078-0414 Novartis Pharmaceuticals Corporation	Zortress	2010-04-22
NDC 0078-0429 Novartis Pharmaceuticals Corporation	GenTeal Severe	2009-09-14
NDC 0078-0569 Novartis Pharmaceuticals Corporation	EXTAVIA	2009-08-14
NDC 0078-0582 Novartis Pharmaceuticals Corporation	Ilaris	2009-06-18
NDC 0078-0561 Novartis Pharmaceuticals Corporation	Exforge HCT	2009-04-04
NDC 0078-0560 Novartis Pharmaceuticals Corporation	Exforge HCT	2009-04-04
NDC 0078-0545 Novartis Pharmaceuticals Corporation	Stalevo	2008-09-26
NDC 0078-0592 Novartis Pharmaceuticals Corporation	Tasigna	2007-10-29
NDC 0078-0526 Novartis Pharmaceuticals Corporation	Tasigna	2007-10-29
NDC 0078-0503 Novartis Pharmaceuticals Corporation	Exelon	2007-07-06
NDC 0078-0502 Novartis Pharmaceuticals Corporation	Exelon	2007-07-06
NDC 0078-0490 Novartis Pharmaceuticals Corporation	Exforge	2007-06-20
NDC 0078-0489 Novartis Pharmaceuticals Corporation	Exforge	2007-06-20
NDC 0078-0488 Novartis Pharmaceuticals Corporation	Exforge	2007-06-20
NDC 0078-0435 Novartis Pharmaceuticals Corporation	Reclast	2007-04-01
NDC 0078-0472 Novartis Pharmaceuticals Corporation	Diovan HCT	2006-04-28
NDC 0078-0470 Novartis Pharmaceuticals Corporation	Exjade	2005-11-30
NDC 0078-0469 Novartis Pharmaceuticals Corporation	Exjade	2005-11-30
NDC 0078-0468 Novartis Pharmaceuticals Corporation	Exjade	2005-11-30
NDC 0078-0434 Novartis Pharmaceuticals Corporation	Focalin XR	2005-05-31
NDC 0078-0433 Novartis Pharmaceuticals Corporation	Focalin XR	2005-05-31
NDC 0078-0430 Novartis Pharmaceuticals Corporation	Focalin XR	2005-05-31
NDC 0078-0386 Novartis Pharmaceuticals Corporation	Myfortic	2004-02-27
NDC 0078-0385 Novartis Pharmaceuticals Corporation	Myfortic	2004-02-27
NDC 0078-0409 Novartis Pharmaceuticals Corporation	Stalevo	2003-06-11
NDC 0078-0408 Novartis Pharmaceuticals Corporation	Stalevo	2003-06-11
NDC 0078-0407 Novartis Pharmaceuticals Corporation	Stalevo	2003-06-11
NDC 0078-0424 Novartis Pharmaceuticals Corporation	Ritalin LA	2002-06-05
NDC 0078-0372 Novartis Pharmaceuticals Corporation	Ritalin LA	2002-06-05
NDC 0078-0371 Novartis Pharmaceuticals Corporation	Ritalin LA	2002-06-05
NDC 0078-0370 Novartis Pharmaceuticals Corporation	Ritalin LA	2002-06-05
NDC 0078-0382 Novartis Pharmaceuticals Corporation	Focalin	2001-11-30
NDC 0078-0381 Novartis Pharmaceuticals Corporation	Focalin	2001-11-30
NDC 0078-0387 Novartis Pharmaceuticals Corporation	Zometa	2001-08-20
NDC 0078-0423 Novartis Pharmaceuticals Corporation	Diovan	2001-07-01
NDC 0078-0359 Novartis Pharmaceuticals Corporation	Diovan	2001-07-01
NDC 0078-0358 Novartis Pharmaceuticals Corporation	Diovan	2001-07-01
NDC 0078-0357 Novartis Pharmaceuticals Corporation	Trileptal	2001-05-30
NDC 0078-0401 Novartis Pharmaceuticals Corporation	Gleevec	2001-05-15
NDC 0078-0352 Novartis Pharmaceuticals Corporation	Starlix	2000-12-04
NDC 0078-0351 Novartis Pharmaceuticals Corporation	Starlix	2000-12-04
NDC 0078-0326 Novartis Pharmaceuticals Corporation	Exelon	2000-04-30
NDC 0078-0325 Novartis Pharmaceuticals Corporation	Exelon	2000-04-30
NDC 0078-0324 Novartis Pharmaceuticals Corporation	Exelon	2000-04-30
NDC 0078-0323 Novartis Pharmaceuticals Corporation	Exelon	2000-04-30
NDC 0078-0337 Novartis Pharmaceuticals Corporation	Trileptal	2000-01-30
NDC 0078-0327 Novartis Pharmaceuticals Corporation	Comtan	1999-10-19
NDC 0078-0365 Novartis Pharmaceuticals Corporation	Vivelle-Dot	1999-01-08
NDC 0078-0346 Novartis Pharmaceuticals Corporation	Vivelle-Dot	1999-01-08
NDC 0078-0344 Novartis Pharmaceuticals Corporation	Vivelle-Dot	1999-01-08
NDC 0078-0343 Novartis Pharmaceuticals Corporation	Vivelle-Dot	1999-01-08
NDC 0078-0183 Novartis Pharmaceuticals Corporation	Sandostatin	1998-10-21
NDC 0078-0393 Novartis Pharmaceuticals Corporation	Simulect	1998-05-12
NDC 0078-0331 Novartis Pharmaceuticals Corporation	Simulect	1998-05-12
NDC 0078-0383 Novartis Pharmaceuticals Corporation	Diovan HCT	1998-03-06
NDC 0078-0315 Novartis Pharmaceuticals Corporation	Diovan HCT	1998-03-06
NDC 0078-0314 Novartis Pharmaceuticals Corporation	Diovan HCT	1998-03-06
NDC 0078-0494 Novartis Pharmaceuticals Corporation	TOBI	1997-12-22
NDC 0078-0249 Novartis Pharmaceuticals Corporation	Femara	1997-07-31
NDC 0078-0179 Novartis Pharmaceuticals Corporation	Lamisil	1996-05-10
NDC 0078-0274 Novartis Pharmaceuticals Corporation	Neoral	1995-07-14
NDC 0078-0248 Novartis Pharmaceuticals Corporation	Neoral	1995-07-14
NDC 0078-0246 Novartis Pharmaceuticals Corporation	Neoral	1995-07-14
NDC 0078-0405 Novartis Pharmaceuticals Corporation	Lotrel	1995-03-03
NDC 0078-0404 Novartis Pharmaceuticals Corporation	Lotrel	1995-03-03
NDC 0078-0379 Novartis Pharmaceuticals Corporation	Lotrel	1995-03-03
NDC 0078-0364 Novartis Pharmaceuticals Corporation	Lotrel	1995-03-03
NDC 0078-0241 Novartis Pharmaceuticals Corporation	Sandimmune	1990-03-02
NDC 0078-0240 Novartis Pharmaceuticals Corporation	Sandimmune	1990-03-02
NDC 0078-0853 Novartis Pharmaceuticals Corporation		1989-09-30
NDC 0078-0184 Novartis Pharmaceuticals Corporation	Sandostatin	1988-10-21
NDC 0078-0182 Novartis Pharmaceuticals Corporation	Sandostatin	1988-10-21
NDC 0078-0181 Novartis Pharmaceuticals Corporation	Sandostatin	1988-10-21
NDC 0078-0180 Novartis Pharmaceuticals Corporation	Sandostatin	1988-10-21
NDC 0078-0110 Novartis Pharmaceuticals Corporation	Sandimmune	1983-11-14
NDC 0078-0109 Novartis Pharmaceuticals Corporation	Sandimmune	1983-11-14
NDC 0078-0467 Novartis Pharmaceuticals Corporation	Desferal	1968-04-02
NDC 0078-0440 Novartis Pharmaceuticals Corporation	Ritalin	1955-12-31

Similar & Related FDA Registered Companies

• Advanced Accelerator Applications USA, Inc

Related Finance Registrations

NCAGE Code	04520	NOVARTIS PHARMACEUTICALS CORPORATION!DBA NPS
CAGE Code	04520	NOVARTIS PHARMACEUTICALS CORPORATION NPS
S.A.M. Registration	04520 [2147023]	NOVARTIS PHARMACEUTICALS CORPORATION NPS

U.S. Import Records [external site]

Import ID	Shipment	Cargo Description	Quantity
2020051442848	Anvers,Belgium -> New York, New York	PHARMACEUTICAL FINISHED PRODUCTS TR	1301 BOX
2020051239184	Anvers,Belgium -> New York, New York	PHARMACEUTICAL FINISHED PRODUCTS TR	1301 BOX
2020050939228	Anvers,Belgium -> New York, New York	PHARMACEUTICAL FINISHED PRODUCTS TR	1301 BOX
2020050763108	Anvers,Belgium -> New York, New York	PHARMACEUTICAL FINISHED PRODUCTS TR	1301 BOX
2020050646238	Anvers,Belgium -> New York, New York	PHARMACEUTICAL FINISHED PRODUCTS TR	1301 BOX
2020050562041	Anvers,Belgium -> New York, New York	PHARMACEUTICAL FINISHED PRODUCTS TR	1301 BOX
2020050151390	Anvers,Belgium -> New York, New York	PHARMACEUTICAL FINISHED PRODUCTS TR	1301 BOX
2019102420806	Anvers,Belgium -> New York/Newark Area, Newark, New Jersey	PHARMACEUTICAL FINISHED PRODUCTS	1282 BOX